Evidence map›Paper›PMID 36451010›Full record

ArticleJournal of general internal medicine2023

Cannabis Recreational Legalization and Prevalence of Simultaneous Cannabis and Alcohol Use in the United States.

Priscila Dib Gonçalves, Natalie S Levy, Luis E Segura, Emilie Bruzelius, Anne E Boustead, Deborah S Hasin, Pia M Mauro, Silvia S Martins

Open access · greenAbstract read
In one paragraph

Article in Journal of general internal medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Priscila Dib GonçalvesDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA.
Natalie S LevyDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA.
Luis E SeguraDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA.
Emilie BruzeliusDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA.
Anne E BousteadSchool of Government & Public Policy, University of Arizona, Tucson, USA.
Deborah S HasinDepartment of Psychiatry, Columbia University Irving Medical Center, New York, NY, USA.
Pia M MauroDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA.
Silvia S MartinsDepartment of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th St Room 509, New York, NY, 10032, USA. ssm2183@cumc.columbia.edu.ORCID 0000-0003-3059-9993
Columbia University · USColumbia University Irving Medical Center · USUniversity of Arizona · US

Funding

Substance Abuse Epidemiology Training Program (SAETP) at Columbia UniversityT32DA031099 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DEBORAH S HASIN, Silvia Saboia Martins · 2012 to 2026
$6.1M
Columbia Injury Control Research CenterR49CE002096 · CE · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LI, GUOHUA · 2012 to 2018
$5.5M
Impact of Medical and Recreational Marijuana Laws On Cannabis, Opioids And Psychiatric Medications: National Study of VA Patients, 2000 - 2024R01DA048860 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2019 to 2023
$4.1M
State medical marijuana laws and NSDUH marijuana use and consequences since 2004R01DA037866 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MARTINS, SILVIA SABOIA · 2014 to 2018
$2.3M
Multi-level associations between medical marijuana laws and substance use disorder treatmentK01DA045224 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAURO, PIA M. · 2018 to 2022
$878k
NCIPC CDC HHS R49 CE002096NIDA NIH HHS K01 DA045224NIDA NIH HHS R01 DA037866NIDA NIH HHS R01 DA048860NIDA NIH HHS T32 DA031099
6 · The paper itself

Abstract

backgroundSimultaneous cannabis/alcohol use, using both substances within a short time interval so that their effects overlap, has a greater risk of potential negative consequences than single-substance use and is more common in younger age. Relationships between recreational cannabis laws (RCLs) and changes in simultaneous cannabis/alcohol use prevalence remain untested.

objectiveTo examine trends in simultaneous cannabis/alcohol use from 2008 to 2019, and investigate associations between implementation of RCLs (i.e., presence of active legal dispensaries or legal home cultivation) and simultaneous cannabis/alcohol use in the United States (U.S.).

designRepeated cross-sectional samples from the 2008-2019 U.S. National Survey on Drug Use and Health (NSDUH).

participantsRespondents (51% female) aged 12 and older.

interventionsChanges in simultaneous cannabis/alcohol use before and after RCL implementation (controlling for medical cannabis law implementation) were compared in different age groups (12-20, 21-30, 31-40, 41-50, 51+), using adjusted multi-level logistic regression with state random intercepts and an RCL/age group interaction. MEASUREMENTS: Self-reported simultaneous cannabis/alcohol use.

resultsFrom 2008 to 2019, the overall prevalence of simultaneous cannabis/alcohol use declined among those aged 12-20 but increased in adults aged 21+. Model-based simultaneous cannabis/alcohol use prevalence increased after RCL implementation among respondents aged 21-30 years (+1.2%; aOR= 1.15 [95%CI = 1.04-1.27]), 31-40 years (+1.0; 1.15 [1.04-1.27]), and 41-50 years (+1.75; 1.63 [1.34-1.98]), but not in individuals aged <21 or 51+ years.

conclusionsImplementation of recreational cannabis policies resulted in increased simultaneous use of cannabis and alcohol, supporting the complementarity hypothesis, but only among adults aged 21+. Efforts to minimize harms related to simultaneous cannabis/alcohol use are critical, especially in states with RCLs. Future studies should investigate cultural norms, perceived harm, and motives related to simultaneous use.

Indexed as

CannabisMedical MarijuanaAdultCross-Sectional StudiesFemaleHumansLegislation, DrugMalePrevalenceUnited StatesMedical Marijuanaalcohol usecannabis userecreational cannabis lawssimultaneous cannabis/alcohol use

Identifiers

PMID36451010
PMCPMC10160263
OpenAlexW4310433584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.